Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal co ...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on ...

Sinovac Biotech (SVA) announced that Sinovac has received a formal court order from the Privy Council following the previously announced Privy ...

BEIJING, February 28, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC ...

BEIJING - Sinovac Biotech Ltd. (NASDAQ:SVA), a prominent biopharmaceutical company in China with a market capitalization of $45.31 million, has confirmed the implementation of a court order ...